Ammar Ahmed, MD
Dermatology · Austin, TXNPI 1245421429
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (37.0%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Pfizer at 46.9% of the total. Reporting peaked in 2019 at $1,491 and has fallen 86.8% since, to $197 in 2025. That places this record below the midpoint for dermatology clinicians in TX, where the typical reported total is $4,085.
Across 18 payments — averaging $177.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$1K
- Avita Medical Americas, LLC$1K
- Abbott$286
- Johnson & Johnson$277
- Regeneron Healthcare Solutions, Inc.$100
- Abiomed$18
- plus $14 from 1 others
Across 24 payments — averaging $5938.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$76K
- Avita Medical Americas, LLC$66K
What the payments were for
- Consulting fees$1,00031%
- Travel & lodging$1,18137%
- Food & beverage$90428%
- Education$1063%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 8 | $1,496 |
| Avita Medical Americas, LLC | 1 | $1,000 |
| Abbott | 4 | $286 |
| Johnson & Johnson | 2 | $277 |
| Regeneron Healthcare Solutions, Inc. | 1 | $100 |
| Abiomed | 1 | $18 |
| Strata Skin Sciences, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RECELL$1,000
- Tremfya$277
- XIENCE SKYPOINT$128
- Perclose ProStyle$106
How this compares
$3,191 in reported general payments places this provider in the 45th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 26 | $94,130 |
| Dupixent SyringeDupilumab | 18 | $67,762 |
| Clobetasol Propionate | 77 | $3,345 |
| Fluorouracil | 23 | $1,581 |
| Tacrolimus | 19 | $1,423 |
| Triamcinolone Acetonide | 66 | $996 |
| Metronidazole | 16 | $877 |
| Azelaic Acid | 13 | $771 |
| Ketoconazole | 38 | $562 |
| Clindamycin Phosphate | 15 | $344 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Austin
- Edward LainAustin$2.5M
- Daniel CarrascoAustin$1.1M
- Dale SchaeferAustin$1M
- Heidi PratherAustin$543K
- Ali ShahbazAustin$413K
- Jennifer GordonAustin$150K
- Madalyn NguyenAustin$127K
- William CragunSan Antonio$2.2M
- Alpesh DesaiHouston$1.6M
- Craig TellerBellaire$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.